GenWay BioTech Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
GenWay BioTech General Information
Description
Developer and provider of proteins, antibodies, and other related products for the medical research industry. The company offers a variety of active proteins, secondary antibodies, research reagents, ELISA (enzyme-linked immunosorbent assay) kits, micro-peptides, PCR (polymerase chain reaction) kits, molecular biology products, protein expression, antigen preparation, and antibody development services.
Contact Information
Website
www.genwaybio.comCorporate Office
- 6777 Nancy Ridge Drive
- San Diego, CA 92121
- United States
Corporate Office
- 6777 Nancy Ridge Drive
- San Diego, CA 92121
- United States
GenWay BioTech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GenWay BioTech Comparisons
Industry
Financing
Details
GenWay BioTech Competitors (19)
One of GenWay BioTech’s 19 competitors is Origene, a Formerly VC-backed company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Origene | Formerly VC-backed | Rockville, MD | ||||
| Correlia Biosystems | Venture Capital-Backed | Berkeley, CA | ||||
| EpiGentek | Corporation | Farmingdale, NY | ||||
| ARVYS Proteins | Corporation | Trumbull, CT | ||||
| Novus Biologicals | Formerly PE-Backed | Centennial, CO |
GenWay BioTech Patents
GenWay BioTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140350129-A1 | Diagnostic assay to predict cardiovascular risk | Inactive | 07-Sep-2011 | ||
| CA-2847839-A1 | Diagnostic assay to predict cardiovascular risk | Inactive | 07-Sep-2011 | ||
| JP-2014525593-A | Diagnostic analysis to predict cardiovascular risk | Pending | 07-Sep-2011 | ||
| EP-2753935-A1 | Diagnostic assay to predict cardiovascular risk | Inactive | 07-Sep-2011 | ||
| US-20070048795-A1 | Immunoaffinity separation and analysis compositions and methods | Inactive | 26-Aug-2005 | C07K1/22 |
GenWay BioTech Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
GenWay BioTech FAQs
-
When was GenWay BioTech founded?
GenWay BioTech was founded in 1998.
-
Where is GenWay BioTech headquartered?
GenWay BioTech is headquartered in San Diego, CA.
-
What industry is GenWay BioTech in?
GenWay BioTech’s primary industry is Discovery Tools (Healthcare).
-
Is GenWay BioTech a private or public company?
GenWay BioTech is a Private company.
-
What is GenWay BioTech’s current revenue?
The current revenue for GenWay BioTech is .
-
Who are GenWay BioTech’s investors?
ReAya Holding has invested in GenWay BioTech.
-
Who are GenWay BioTech’s competitors?
Origene, Correlia Biosystems, EpiGentek, ARVYS Proteins, and Novus Biologicals are some of the 19 competitors of GenWay BioTech.
-
When was GenWay BioTech acquired?
GenWay BioTech was acquired on 23-Feb-2017.
-
Who acquired GenWay BioTech?
GenWay BioTech was acquired by Aviva Systems Biology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
